These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16799160)

  • 41. Enhanced surface attachment of protein-type targeting ligands to poly(lactide-co-glycolide) nanoparticles using variable expression of polymeric acid functionality.
    McCarron PA; Marouf WM; Donnelly RF; Scott C
    J Biomed Mater Res A; 2008 Dec; 87(4):873-84. PubMed ID: 18228271
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Design and optimization of NSAID loaded nanoparticles.
    Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
    Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Modulation of protein delivery from modular polymer scaffolds.
    Lee M; Chen TT; Iruela-Arispe ML; Wu BM; Dunn JC
    Biomaterials; 2007 Apr; 28(10):1862-70. PubMed ID: 17184836
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
    Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
    Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bupivacaine-loaded biodegradable poly(lactic-co-glycolic) acid microspheres I. Optimization of the drug incorporation into the polymer matrix and modelling of drug release.
    Zhang H; Lu Y; Zhang G; Gao S; Sun D; Zhong Y
    Int J Pharm; 2008 Mar; 351(1-2):244-9. PubMed ID: 18024022
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The intracellular uptake ability of chitosan-coated Poly (D,L-lactide-co-glycolide) nanoparticles.
    Kim BS; Kim CS; Lee KM
    Arch Pharm Res; 2008 Aug; 31(8):1050-4. PubMed ID: 18787796
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Collagen/PLGA microparticle composites for local controlled delivery of gentamicin.
    Schlapp M; Friess W
    J Pharm Sci; 2003 Nov; 92(11):2145-51. PubMed ID: 14603500
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of poly(D,L-lactide-co-glycolide) microparticles with polyelectrolyte self-assembled multilayer surfaces on the cross-presentation of exogenous antigens.
    Yang YW; Hsu PY
    Biomaterials; 2008 Jun; 29(16):2516-26. PubMed ID: 18329708
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Controlled release of amoxicillin from hydroxyapatite-coated poly(lactic-co-glycolic acid) microspheres.
    Xu Q; Czernuszka JT
    J Control Release; 2008 Apr; 127(2):146-53. PubMed ID: 18325617
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Experiments on a sub-unit vaccine encapsulated in microparticles and its efficacy against Brucella melitensis in mice.
    Estevan M; Gamazo C; Grilló MJ; Del Barrio GG; Blasco JM; Irache JM
    Vaccine; 2006 May; 24(19):4179-87. PubMed ID: 16481077
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Polyester microparticles as a vaccine delivery system for brucellosis: influence of the polymer on release, phagocytosis and toxicity.
    Murillo M; Gamazo C; Irache JM; Goñi MM
    J Drug Target; 2002 May; 10(3):211-9. PubMed ID: 12075822
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alendronate-loaded nanoparticles deplete monocytes and attenuate restenosis.
    Cohen-Sela E; Rosenzweig O; Gao J; Epstein H; Gati I; Reich R; Danenberg HD; Golomb G
    J Control Release; 2006 Jun; 113(1):23-30. PubMed ID: 16697068
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Development of an anti-infection nano-hydroxypatite drug delivery microsphere and its drug-release in vitro].
    Wang YF; Jin AM; Wei K; Wang XD; Tang SH; Min SX
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):754-6. PubMed ID: 16793592
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro release and antibacterial activity of poly (oleic/linoleic acid dimer: sebacic acid)-gentamicin.
    Yang XF; Zeng FD; Zhou ZB; Huang KX; Xu HB
    Acta Pharmacol Sin; 2003 Apr; 24(4):306-10. PubMed ID: 12676068
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influence of the co-encapsulation of different excipients on the properties of polyester microparticle-based vaccine against brucellosis.
    Murillo M; Irache JM; Estevan M; Goñi MM; Blasco JM; Gamazo C
    Int J Pharm; 2004 Mar; 271(1-2):125-35. PubMed ID: 15129979
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of microparticles prepared by spray-drying as a vaccine delivery system against brucellosis.
    Murillo M; Gamazo C; Goñi MM; Irache JM; Blanco-Príeto MJ
    Int J Pharm; 2002 Aug; 242(1-2):341-4. PubMed ID: 12176275
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modifying the release of gentamicin from microparticles using a PLGA blend.
    Friess W; Schlapp M
    Pharm Dev Technol; 2002 May; 7(2):235-48. PubMed ID: 12066578
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Design and in vitro evaluation of gentamicin-Eudragit microspheres intended for intra-ocular administration.
    Al-Kassas R
    J Microencapsul; 2004 Feb; 21(1):71-81. PubMed ID: 14718187
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relating the phagocytosis of microparticles by alveolar macrophages to surface chemistry: the effect of 1,2-dipalmitoylphosphatidylcholine.
    Evora C; Soriano I; Rogers RA; Shakesheff KN; Hanes J; Langer R
    J Control Release; 1998 Feb; 51(2-3):143-52. PubMed ID: 9685911
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synergy tests by E test and checkerboard methods of antimicrobial combinations against Brucella melitensis.
    Orhan G; Bayram A; Zer Y; Balci I
    J Clin Microbiol; 2005 Jan; 43(1):140-3. PubMed ID: 15634962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.